Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection

Mucosal Immunology

Volumn 3, Issue 3, 2010, Pages 312-321

  Feinen, B ^a   Jerse, A E ^b   Gaffen, S L ^c   Russell, M W ^a,d  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ESTRADIOL; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; STREPTOMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE DELETION; GONORRHEA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NEISSERIA GONORRHOEAE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TH17 CELL; TISSUE CULTURE;

EID: 77951483708     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.139     Document Type: Article

References (55)

1. Harrington , L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 , 1123-1132 ( 2005 ).
2. Park , H. et al. A distinct lineage of CD4T cells regulates tissue infl ammation by producing interleukin 17. Nat. Immunol. 6 , 1133-1141 ( 2005 ). (Pubitemid 41541791)
3. Kotake , S. et al. IL-17 in synovial fl uids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103 , 1345-1352 ( 1999 ). (Pubitemid 29218305)
4. Langrish , C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune infl ammation. J. Exp. Med. 201 , 233-240 ( 2005 ).
5. Happel , K. I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202 , 761-769 ( 2005 ).
6. Higgins , S. C. , Jarnicki , A. G. , Lavelle , E. C. & Mills , K. H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis : role of IL-17-producing T cells. J. Immunol. 177 , 7980-7989 ( 2006 ).
7. Khader , S. A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8 , 369-377 ( 2007 ).
8. Shibata , K. , Yamada , H. , Hara , H. , Kishihara , K. & Yoshikai , Y. Resident Vδ 1+γδ T cells control early infi ltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178 , 4466-4472 ( 2007 ). (Pubitemid 46492398)
9. Ye , P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194 , 519-527 ( 2001 ). (Pubitemid 32835046)
10. Yu , J. J. et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to infl amed bone requires IL-17 receptor-dependent signals. Blood 109 , 3794-3802 ( 2007 ).
11. Weaver , C. T. , Harrington , L. E. , Mangan , P. R. , Gavrieli , M. & Murphy , K. M. Th17: an effector CD4T cell lineage with regulatory T cell ties. Immunity 24 , 677-688 ( 2006 ). (Pubitemid 43867371)
12. Korn , T. , Bettelli , E. , Oukka , M. & Kuchroo , V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27 , 485-517 ( 2009 ).
13. Ouyang , W. , Kolls , J. K. & Zheng , Y. The biological functions of T helper 17 cell effector cytokines in infl ammation. Immunity 28 , 454-467 ( 2008 ). (Pubitemid 351471762)
14. LeibundGut-Landmann , S. et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin. Nat. Immunol. 8 , 630-638 ( 2007 ).
15. Verreck , F. A. et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101 , 4560-4565 ( 2004 ).
16. Schulz , S. M. et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar Enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J. Immunol. 181 , 7891-7901 ( 2008 ).
17. Prause , O. , Laan , M. , Lotvall , J. & Linden , A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol. 462 , 193-198 ( 2003 ). (Pubitemid 36187422)
18. Ruddy , M. J. , Shen , F. , Smith , J. B. , Sharma , A. & Gaffen , S. L. Interleukin- 17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for infl ammation and neutrophil recruitment. J. Leuk. Biol. 76 , 135-144 ( 2004 ). (Pubitemid 38857180)
19. Shen, F. , Ruddy , M. J. , Plamondon , P. & Gaffen , S. L. Cytokines link osteoblasts and infl ammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J. Leuk. Biol. 77 , 388-399 ( 2005 ). (Pubitemid 40289569)
20. Witowski , J. et al. IL-17 stimulates intraperitoneal neutrophil infi ltration through the release of GROα chemokine from mesothelial cells. J. Immunol. 165 , 5814-5821 ( 2000 ).
21. Huang , W. , Na , L. , Fidel , P. L. & Schwarzenberger , P. Requirement of interleukin-17A for systemic anti- Candida albicans host defense in mice. J. Infect. Dis. 190 , 624-631 ( 2004 ). (Pubitemid 38982105)
22. Conti , H. R. et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206 , 299-311 ( 2009 ).
23. Liang , S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 , 2271-2279 ( 2006 ).
24. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. World Health Organization ( 2001 ).
25. Notifi able diseases/deaths in selected cities weekly information. MMWR 55 , 1396-2140 ( 2009 ).
26. Noble , R. C. , Kirk , N. M. , Slagel , W. A. , Vance , B. J. & Somes , G. W. Recidivism among patients with gonococcal infection presenting to a venereal disease clinic. Sex Transm. Dis. 4 , 39-43 ( 1977 ).
27. Edwards , J. L. & Apicella , M. A. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17 , 965-981 ( 2004 ).
28. Hedges , S. R. , Sibley , D. A. , Mayo , M. S. , Hook , E. W. 3rd & Russell , M. W. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae : effects of concomitant infections. J. Infect. Dis. 178 , 742-751 ( 1998 ).
29. Fichorova , R. N. , Desai , P. J. , Gibson , F. C. 3rd & Genco , C. A. Distinct proinfl ammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect. Immun. 69 , 5840-5848 ( 2001 ).
30. Naumann , M. , Wessler , S. , Bartsch , C. , Wieland , B. & Meyer , T. F. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor B and activator protein 1 and the induction of infl ammatory cytokines. J. Exp. Med. 186 , 247-258 ( 1997 ). (Pubitemid 27328025)
31. Ramsey , K. H. et al. Infl ammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172 , 186-191 ( 1995 ).
32. Simpson , S. D. , Ho , Y. , Rice , P. A. & Wetzler , L. M. T lymphocyte response to Neisseria gonorrhoeae porin in individuals with mucosal gonococcal infections. J. Infect. Dis. 180 , 762-773 ( 1999 ). (Pubitemid 29411363)
33. Jerse , A. E. et al. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179 , 911-920 ( 1994 ).
34. Jerse , A. E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67 , 5699-5708 ( 1999 ).
35. Packiam , M. , Veit , S. J. , Anderson , D. J. , Ingalls , R. R. & Jerse , A. E. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78 , 433-440 ( 2010 ).
36. Kobayashi , Y. The role of chemokines in neutrophil biology. Front Biosci. 13 , 2400-2407 ( 2008 ). (Pubitemid 351599693)
37. Russell , M. W. & Hook , E. W. Gonorrhea. In Vaccines for Biodefense and Emerging and Neglected Diseases (Barrett, A.D.T., and Stanberry, L.R., eds) 963-981 ( Academic Press, London , 2009 ).
38. Jerse , A. E. et al. Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli. Infect. Immun. 70 , 2549-2558 ( 2002 ).
39. Song , W. et al. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17β-estradiol- treated mice. Vaccine 26 , 5741-5751 ( 2008 ).
40. Criss , A. K. , Katz , B. Z. & Seifert , H. S. Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes. Cell. Microbiol. 11 , 1074-1087 ( 2009 ).
41. Wu , H. , Soler-Garcia , A. A. & Jerse , A. E. A strain-Specific catalase mutation and mutation of the metal-binding transporter gene mntC attenuate Neisseria gonorrhoeae in vivo but not by increasing susceptibility to oxidative killing by phagocytes. Infect. Immun. 77 , 1091-1102 ( 2009 ).
42. Simons , M. P. , Nauseef , W. M. & Apicella , M. A. Interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes. Infect. Immun. 73 , 1971-1977 ( 2005 ).
43. Casey , S. G. , Veale , D. R. & Smith , H. Demonstration of intracellular growth of gonococci in human phagocytes using spectinomycin to kill extracellular organisms. J. Gen. Microbiol. 113 , 395-398 ( 1979 ). (Pubitemid 10236589)
44. Plummer , F. A. et al. Epidemiologic evidence for the development of serovar-Specific immunity after gonococcal infection. J. Clin. Invest. 83 , 1472-1476 ( 1989 ).
45. Schmidt , K. A. et al. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex Transm. Dis. 28 , 555-564 ( 2001 ).
46. Price , G. A. , Hobbs , M. M. & Cornelissen , C. N. Immunogenicity of gonococcal transferrin binding proteins during natural infections. Infect. Immun. 72 , 277-283 ( 2004 ).
47. Hedges , S. R. , Mayo , M. S. , Mestecky , J. , Hook , E. W. 3rd & Russell , M. W. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67 , 3937-3946 ( 1999 ). (Pubitemid 29357013)
48. Ram , S. et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 193 , 281-295 ( 2001 ). (Pubitemid 32524512)
49. Smith , H. , Parsons , N. J. & Cole , J. A. Sialylation of neisserial lipopolysaccharide: a major infl uence on pathogenicity. Microb. Pathog. 19 , 365-377 ( 1995 ). (Pubitemid 26092169)
50. Rice , P. A. , Vayo , H. E. , Tam , M. R. & Blake , M. S. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164 , 1735-1748 ( 1986 ).
51. Long , F. , Rouquette-Loughlin , C. , Shafer , W. M. & Yu , E. W. Functional cloning and characterization of the multidrug effl ux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Antimicrob Agents Chemother 52 , 3052-3060 ( 2008 ).
52. Nassif , X. & So , M. Interaction of pathogenic neisseriae with nonphagocytic cells. Clin. Microbiol. Rev. 8 , 376-388 ( 1995 ).
53. Awasthi , A. K. V. IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal infl ammation. Nat. Immunol. 10 , 568-570 ( 2009 ).
54. Imarai , M. et al. Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae. Infect. Immun. 76 , 5456-5465 ( 2008 ).
55. Cohen , M. S. et al. Human experimentation with Neisseria gonorrhoeae : rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169 , 532-537 ( 1994 ).